Prehevbrio
Payments companies reported to CMS as associated with Prehevbrio. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Prehevbrio, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Prehevbrio
These are the largest totals companies reported as associated with Prehevbrio. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mark Schleiss | Minneapolis, MN | Pediatrics | $9,375.00 |
| James Dale | Memphis, TN | Infectious Disease | $8,250.00 |
| John Modlin | Lebanon, NH | Pediatric Infectious Diseases | $5,250.00 |
| Mauricio Lisker Melman | Saint Louis, MO | Gastroenterology (Internal Medicine) | $2,880.00 |
| Anthony Martinez | Buffalo, NY | Internal Medicine | $2,500.00 |
| Michael Decker | Baxter, TN | Infectious Disease | $940.67 |
| Eddy Bresnitz | Bala Cynwyd, PA | Pulmonary Disease | $900.00 |
| Rajesh Maheshwari | San Ramon, CA | Family Medicine | $215.28 |
| Rajiv Ahuja | Fremont, CA | Internal Medicine | $190.88 |
| Woun Seok | Duluth, GA | Family Medicine | $103.56 |
Prescribed Prehevbrio?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.